HomeCompareEUCRU vs MO

EUCRU vs MO: Dividend Comparison 2026

EUCRU yields 19.96% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $4.9K in total portfolio value· pulled ahead in Year 10
10 years
EUCRU
EUCRU
● Live price
19.96%
Share price
$10.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.8K
Annual income
$6,710.30
Full EUCRU calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — EUCRU vs MO

📍 MO pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEUCRUMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EUCRU + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EUCRU pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EUCRU
Annual income on $10K today (after 15% tax)
$1,696.61/yr
After 10yr DRIP, annual income (after tax)
$5,703.76/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, MO beats the other by $18,919.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EUCRU + MO for your $10,000?

EUCRU: 50%MO: 50%
100% MO50/50100% EUCRU
Portfolio after 10yr
$75.3K
Annual income
$17,839.42/yr
Blended yield
23.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

EUCRU
No analyst data
Altman Z
6.6
Piotroski
4/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EUCRU buys
0
MO buys
0
No recent congressional trades found for EUCRU or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEUCRUMO
Forward yield19.96%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$72.8K$77.7K
Annual income after 10y$6,710.30$28,968.54
Total dividends collected$41.4K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EUCRU vs MO ($10,000, DRIP)

YearEUCRU PortfolioEUCRU Income/yrMO PortfolioMO Income/yrGap
1$12,696$1,996.01$10,558$768.31+$2.1KEUCRU
2$15,953$2,368.35$11,352$1,015.87+$4.6KEUCRU
3$19,851$2,781.24$12,482$1,367.86+$7.4KEUCRU
4$24,475$3,234.40$14,103$1,883.39+$10.4KEUCRU
5$29,915$3,726.92$16,472$2,664.91+$13.4KEUCRU
6$36,267$4,257.31$20,024$3,897.79+$16.2KEUCRU
7$43,629$4,823.54$25,537$5,933.74+$18.1KEUCRU
8$52,106$5,423.11$34,478$9,476.77+$17.6KEUCRU
9$61,806$6,053.11$49,776$16,022.63+$12.0KEUCRU
10← crossover$72,843$6,710.30$77,699$28,968.54$4.9KMO

EUCRU vs MO: Complete Analysis 2026

EUCRUStock

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Full EUCRU Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this EUCRU vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EUCRU vs SCHDEUCRU vs JEPIEUCRU vs OEUCRU vs KOEUCRU vs MAINEUCRU vs PMEUCRU vs BTIEUCRU vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.